BAYCOL DIN 02241466
Status: Cancelled Post Market
Holder: BAYER INC
Health Canada record
| Active ingredient(s) | CERIVASTATIN SODIUM 0.4 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | C10AA06 CERIVASTATIN |
|---|
| Original market date | 06-Jan-2000 |
|---|
| Current status date | 26-Oct-2001 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Bayer Inc — licence 101029, currently licensed, last inspection rating C (2023-02-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CERIVASTATIN SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02243223 | BAYCOL | BAYER INC | Tablet | CERIVASTATIN SODIUM 0.8 MG | Cancelled Post Market |
| 02237325 | BAYCOL (0.2MG) | BAYER INC | Tablet | CERIVASTATIN SODIUM 0.2 MG | Cancelled Post Market |
| 02237326 | BAYCOL (0.3MG) | BAYER INC | Tablet | CERIVASTATIN SODIUM 0.3 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 1617 | 1999-12-22 | Supplement to a New Drug Submission (SNDS) | NEW STRENGTH |
Request a quote for BAYCOL
How to read a Canadian DIN record